The Effects of Intensive Blood Pressure Control on Cardiovascular Outcomes Based on 10-Year ASCVD Risk Score: An Analysis of a Clinical Trial

Table 3

Secondary outcomes in the intensive- and standard-treatment group.

Group	ASCVD%	Secondary outcomes
		MI	Non-MI ACS	Stroke	HF	CVD death
Intensive/standard	<7.5%	0.39 (0.07–2.01), 0.261	0.01 (0.00–1295), 0.469	3.84 (0.42–34.36), 0.229	0.95 (0.23–3.82), 0.949	0.96 (0.13–6.81), 0.967
	7.5%–10%	0.95 (0.27–3.30), 0.945	1.45 (0.24–8.10), 0.681	0.24 (0.02–2.14), 0.202	1.87 (0.17–20.68), 0.608	0.47 (0.11–1.90), 0.296
	10%–15%	0.48 (0.20–1.11), 0.087	0.58 (0.17–1.98), 0.386	1.79 (0.52–6.12), 0.341	0.51 (0.21–1.19), 0.123	0.53 (0.14–1.47), 0.188
	≥15%	0.92 (0.68–1.24), 0.585	1.13 (0.69–1.87), 0.611	0.81 (0.56–1.18), 0.292	0.60 (0.42–0.86), 0.006	0.58 (0.36–0.93), 0.024
	Total	0.83 (0.63–1.09), 0.183	0.99 (0.64–0.154), 0.994	0.88 (0.62–1.24),0.472	0.61 (0.44–0.84), 0.003	0.56 (0.37–0.84), 0.006

Data were presented as hazard ratio (95% confidence interval), value. The bold value data indicates its significance. ASCVD: Atherosclerotic Cardiovascular Disease, MI: myocardial infarction, ACS: acute coronary syndrome, HF: heart failure, CVD: cardiovascular disease.